fold-close-button

Research has revolutionised the lives of people with asthma

campaign-banner

Section Menu

Connect with us

We're here to help.

Contact us or call 1800 ASTHMA (1800 278 462)

  • Follow us on Twitter
  • Like us on Facebook
  • Subscribe to YouTube

Montelukast latest information

Due to recent media attention of Montelukast, the Therapeutic Drugs Administration (TGA) – the Commonwealth body responsible for regulating medicines in Australia – conducted a safety review of the medication (April 2018).

This concluded there is an association between Montelukast and psychiatric side effects (such as agitation, sleep disturbance and depression) including, in rare cases, suicidal thinking and behaviour. We urge doctors and parents to monitor children taking montelukast and be prepared to cease treatment if side-effects are suspected.

Download the Montelukast Fact Sheet below for more information.

Resources

National Supporters

Principal Partner:


Dyson-Logo-1

 

 

 


 
 
Program Partners:

air-physio-logo

Health logo 

bird_healthcare_logo


 
 

Livingstone-logo

 

teacher-health-logo

 whitemagic_logo

 
Research Partners:

ENJO-Logo-RGB

 

 

   
Campaign Partner:  ooh-unmissable
 

  flo_circle_logo_web_use_colour

logo tarkett blue

 

 

State Supporters

ACT-Health-logo
nsw-health-logo  Qld_Gov   
Fay Fuller Foundation Logo
 SA_partners_electranet  SA_partners_sapower  

 

map-cross-close

Please select your location

select-state-map

Western Australia Northern Territory Queensland Queensland Australian Capital Territory Australia Capital Territory New South Wales South Australia Victoria Tasmania

So we can provide you with the most correct information, please select your location below:

This website is a collaboration between Asthma Australia and Asthma Foundations ACT, NSW, NT, QLD, VIC, WA, TAS and SA